NCT06099067 - Harmonizing RCT-Duplicate Emulations In A Real World Replication Program (HARRP) | Biotech Hunter

Enrollment

239,990

Participants

Timeline

Start Date

May 15, 2020

Primary Completion Date

August 31, 2023

Study Completion Date

August 31, 2023

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Canagliflozin

Canagliflozin dispensing claim is used as the exposure drug in CANVAS replication

DRUG

DPP4 inhibitor

DPP4 inhibitor dispensing claim is used as the reference drug in CANVAS and LEADER replications

DRUG

Liraglutide

Liraglutide dispensing claim is used as the Exposure drug in LEADER replication

DRUG

Saxagliptin

Saxagliptin dispensing claim is used as the Exposure drug in SAVOR-TIMI replication

DRUG

2nd generation Sulfonylurea

2nd generation Sulfonylurea dispensing claim is used as the Exposure drug in SAVOR-TIMI replication

Trial Locations (1)

Research Site, Gothenburg